Skip to main content

United States News All stories

Every story in this section, newest first — page 261 of 373.

Grafa
Health

ADC Therapeutics secures cash runway to 2028 amid pivotal clinical momentum

ADC Therapeutics (NYSE: ADCT), a commercial-stage biotechnology company improving the lives of cancer patients with its next-generation antibody-drug conjugates (ADCs), reported a steady fourth quarter for 2025 and a significantly strengthened balance sheet on Tuesday.

Read more: ADC Therapeutics secures cash runway to 2028 amid pivotal clinical momentum
Grafa
Health

Q32 Bio extends cash runway to 2027 following program sale and financing

Q32 Bio (NASDAQ:QTTB), a clinical-stage biotechnology company developing therapies for autoimmune and inflammatory diseases, provided a fourth-quarter 2025 corporate update that highlights a significantly strengthened balance sheet and clinical progress.

Read more: Q32 Bio extends cash runway to 2027 following program sale and financing
Grafa
Retail

United Natural Foods posts higher profit despite sales dip following optimization

United Natural Foods (NYSE:UNFI), the largest publicly traded wholesale distributor of health and specialty foods in North America, reported a significant increase in profitability for its fiscal second quarter ended January 31, 2026.

Read more: United Natural Foods posts higher profit despite sales dip following optimization
Grafa
Technology

LiveOne signs multi-year extension with Merlin for independent music catalog

LiveOne (NASDAQ:LVO), the music and entertainment technology platform, announced on Tuesday a multi-year extension of its global licensing partnership with Merlin, the preeminent digital rights solicitor for the independent music sector.

Read more: LiveOne signs multi-year extension with Merlin for independent music catalog
Grafa
Technology

ASE Technology February revenue climbs 15.9% as chip testing demand surges

ASE Technology Holding (NYSE:ASX), the world’s largest provider of independent semiconductor manufacturing services in assembly and testing, reported unaudited consolidated net revenues of NT$52,097 million ($1,653 million) for February 2026.

Read more: ASE Technology February revenue climbs 15.9% as chip testing demand surges